Results 281 to 290 of about 1,203,966 (394)

Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity. [PDF]

Proc Natl Acad Sci U S A
Bentley K, Statkute E, Murrell I, Fielding CA, Antrobus R, Preston H, Kerr-Jones L, Cochrane D, Brizic I, Lehner PJ, Wilkinson GWG, Wang ECY, Graham SC, Weekes MP, Stanton RJ.   +14 more
europepmc   +1 more source

Glycoprotein synthesis by the perfused livers from normal and tumour-bearing rats. [PDF]

, 1967
D. Burston, M E Apsey
openalex   +1 more source

Possibilities of Inner Ear Barrier Models for Otologic Drug Development

Advanced Therapeutics, EarlyView.
This review examines innovative organ chip models that reconstruct critical inner ear barriers, addressing a fundamental challenge in otologic drug development: the limited understanding of pharmaceutical behavior across these complex barriers. By replicating these barriers, the advanced models offer promising alternatives to traditional testing ...
Yeji Ahn, Seonmin Choi, Minju Kim, Zachary Estlack, Daniel Brown, Jaehong Key, Young Joon Seo, Jungkyu Kim   +7 more
wiley   +1 more source

Comparison of Clinical and Imaging Parameters in Patients With Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Prospective Observational Study. [PDF]

Cureus
Devi E, Chandan SK, Rani D, Mohapatra DP, Verma S.   +4 more
europepmc   +1 more source

Isolation of Glycopeptides from Rat Liver Microsomes Involved in the Biosynthesis of Plasma Glycoprotein

, 1968
Yu‐Teh Li, Su‐Chen Li, M. R. Shetlar
openalex   +1 more source

Structural Characterization and AI‐Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS‐CoV‐2 Variants

Advanced Therapeutics, EarlyView.
This study characterizes a camelid antibody (B10) with potent neutralizing activity against SARS‐CoV‐2 Wildtype and Omicron variants. Through binding assays, epitope mapping, pseudovirus neutralization, and AI‐driven modeling, the antibody is shown to target conserved RBD regions in a closed Spike conformation.
Katja Hanack, Urszula Orzeł, Anja Schlör, Sourabh Mehta, Anandi Krishnan, Slawomir Filipek, Rushika Patel, Madhvi Joshi, Markus Hoffmann, Stefan Pöhlmann, Chaitanya Joshi, Dorian Liepmann, Ramasamy Paulmurugan, Venkatesan Renugopalakrishnan   +13 more
wiley   +1 more source

A Mutation-Based Reverse Vaccinology Approach Considering Variability in Epitopes to Combat Multi-Strains: A Study Using Glycoprotein of LASV. [PDF]

J Cell Mol Med
Mishra SK, Patil RB, Sherpa AT, Borhan Uddin M, Harun-Or-Rashid M, Ahmed M, Dawoud TM, Georrge JJ.   +7 more
europepmc   +1 more source

First‐Principles Structure–Activity Relationship Insights Into Phenolic Scaffolds: QSAR Modeling and Drug‐Likeness Screening

Advanced Theory and Simulations, EarlyView.
Integrated machine learning framework for phenolic derivatives: classification (toxicity) and regression (logP) models identify top drug‐like compounds. Random Forest outperformed for toxicity, while Linear Regression best predicted logP. A weighted scoring approach prioritized five safe, lipophilicity‐optimized candidates, supporting rational ...
Houria Nacer, Sridhar Priyankha, Gopal Hema, Anouar Zerouali, Hamza Haddag, Muneerah Mogren Al Mogren, Muthuramalingam Prakash, Majdi Hochlaf   +7 more
wiley   +1 more source

Halobacterial glycoprotein biosynthesis [PDF]

Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1987
openaire   +4 more sources

Rapid glycoprotein evolution enables variant interactions in herpes simplex virus type 1. [PDF]

Virus Evol
Höfler T, Zeitlow M, Kim JY, Wyler E, Trimpert J.   +4 more
europepmc   +1 more source